Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Easton Pharmaceuticals Inc (EAPH)
OTHER OTC:EAPH
Easton Pharmaceuticals (EAPH) Stock Price & Analysis
87 Followers
EAPH Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
EAPH FAQ
What was Easton Pharmaceuticals Inc’s price range in the past 12 months?
Currently, no data Available
What is Easton Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Easton Pharmaceuticals Inc’s upcoming earnings report date?
Easton Pharmaceuticals Inc’s upcoming earnings report date is Jun 13, 2019 which is 1797 days ago.
How were Easton Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Easton Pharmaceuticals Inc overvalued?
According to Wall Street analysts Easton Pharmaceuticals Inc’s price is currently Overvalued.
Does Easton Pharmaceuticals Inc pay dividends?
Easton Pharmaceuticals Inc does not currently pay dividends.
What is Easton Pharmaceuticals Inc’s EPS estimate?
Easton Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Easton Pharmaceuticals Inc have?
Easton Pharmaceuticals Inc has 932,729,000 shares outstanding.
What happened to Easton Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Easton Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in EAPH
---
Company Description
Easton Pharmaceuticals Inc
Easton Pharmaceuticals, Inc. engages in the design, development, and marketing of drugs, therapeutic, and cosmetic healthcare products. It owns wound-healing drug and topically delivered drugs to treat cancer and other therapeutic products. The company was founded by John K. Easton on February 4, 1997 and is headquartered in Toronto, Canada.
---
---